MATTHEW HOLCOMB: Open Payments
NPI 1033406855 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,001 in 47 payments from 16 companies in 2025. Trend: 2023 $689 · 2024 $641 · 2025 $1,001
Food & beverage: $1,001
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 17 | $304 |
| Procept Biorobotics Corporation | 1 | $160 |
| ACCORD HEALTHCARE, INC. | 5 | $100 |
| Astellas Pharma US Inc | 5 | $78 |
| Janssen Biotech, Inc. | 4 | $67 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| ABBVIE INC. | 2 | $41 |
| Myriad Genetic Laboratories, Inc. | 2 | $39 |
| Teleflex LLC | 1 | $37 |
| Dendreon Pharmaceuticals LLC | 1 | $32 |
Products named: GEMTESA, AQUABEAM ROBOTIC SYSTEM, Camcevi, Xtandi, ERLEADA, PLUVICTO, BOTOX, PROLARIS.
Industry payments across TX — which companies pay providers there.
